Rankings
▼
Calendar
SYRE Q1 2019 Earnings — Spyre Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
SYRE
Spyre Therapeutics, Inc.
$3B
Q1 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
$0
Operating Income
-$18M
Net Income
-$17M
EPS (Diluted)
$-14.79
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$16M
Free Cash Flow
-$16M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$129M
Total Liabilities
$12M
Stockholders' Equity
$116M
Cash & Equivalents
$86M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$2M
-100.0%
Gross Profit
$0
$0
—
Operating Income
-$18M
-$8M
-114.2%
Net Income
-$17M
-$8M
-111.4%
← FY 2019
All Quarters
Q2 2019 →